Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2015 |
| Author/s |
author: Serafin Morales Jose A Garcia-Saenz Eva Carrasco Miguel Martin |
| Publication date | February 17, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |